Page 1 of 4 - Mycophenolate Mofetil Capsules and Tablets Material Safety Data Sheet 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION Common/Trade Name: Mycophenolate Mofetil Capsules and Tablets Chemical Name: 2-morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5 ...
Only physicians experienced in immunosuppressive therapy and management of solid organ transplant patients should use CellCept (mycophenolate mofetil).
PAR Mycophenolate mofetil 500mg film-coated Tablets UK/H/1922/001/DC 2 LAY SUMMARY On 7 th October 2009, the MHRA granted Dr. Reddy's Laboratories (UK) Limited a Marketing Authorisation (licence) for the medicinal product Mycophenolate mofetil 500mg film-coated Tablets (PL 08553/0359, UK/H/1922 ...
MHRA PAR; MYCOPHENOLATE MOFETIL 500 MG FILM-COATED TABLETS, PL 17780/0301 2 Lay summary The Medicines and Healthcare products Regulatory Agency (MHRA) granted A Winthrop Pharmaceuticals UK Limited a Marketing Authorisation (licence) for the medicinal product Mycophenolate Mofetil 500 mg film ...
SECTION EDITOR: GEORGE J. HRUZA, MD; ASSISTANT SECTION EDITORS: LYNN A. CORNELIUS, MD; JOHN STARR, MD The Effectiveness of Mycophenolate Mofetil
CAMBRIDGESHIRE JOINT PRESCRIBING GROUP DECISION DOCUMENT Mycophenolate Mofetil _ILD_ - Decision May 2010
CellCept ® What is CellCept ®? CellCept (mycophenolate mofetil) is an immunosuppressive medication used to lower the body's natural immunity in patients who receive organ transplants.
P ATIENT I NFORMATION ON MYCOPHENOLATE MOFETIL (Brand name:Cellcept) Australian Rheumatology Association This information sheet has been produced by the Australian Rheumatology Association to help you understand the medicine that has been prescribed for you.
Material Safety Data Sheet Mycophenolate mofetil sc-200971 Hazard Alert Code Key: EXTREME HIGH MODERATE LOW Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME Mycophenolate mofetil STATEMENT OF HAZARDOUS NATURE CONSIDERED A HAZARDOUS SUBSTANCE ACCORDING TO OSHA 29 CFR 1910.1200.